Positions
External Positions
Sebastian Baumgarten is starting a new group for RNA biology of malaria parasites at the Institut Pasteur, Paris, in 2021. There are open positions for a PostDoc and PhD student who would like to join. Both positions focus on mRNA modifications and are fully funded through an ERC Starting Grant for an initial period of three years. Sebastian is looking for candidates with a strong background in molecular/RNA biology and/or epigenetics and who like a new challenge. Here are the official job listings:
Job Category: General & Administrative – Ionis
For more than 30 years, Ionis Pharmaceuticals has been the leader in RNA-targeted therapy, pioneering new markets and
changing standards of care with our novel antisense technology. Scientific innovation began and continues at Ionis with the
understanding that sick people depend on us.
As the first company to fully harness the power of RNA technology for human therapeutics, our platform continues to
revolutionize drug discovery and transform the lives of patients with unmet needs. Our medicines span multiple therapeutic
areas, routes of administration and diverse patient populations. Ionis innovation is driving meaningful progress for many of the
most challenging health issues.
We are building upon our innovative research and drug development excellence to provide greater value to patients. Based on
the breadth and remarkable progress of our pipeline, Ionis is projecting to have a vast number of new transformational
products on the market in the coming years and growing our commercial capabilities. We are well positioned financially to
deliver on our strategic goals.
Ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. Our
success is a direct result of our outstanding employees. We are interested in bringing together a diverse workforce, comprised
of individuals from different backgrounds and with unique skill sets, into our creative and productive environment. Join us and
experience our unique culture while you develop and expand your career.
Job Category: Research – Ionis
For more than 30 years, Ionis Pharmaceuticals has been the leader in RNA-targeted therapy, pioneering new markets and
changing standards of care with our novel antisense technology. Scientific innovation began and continues at Ionis with the
understanding that sick people depend on us.
As the first company to fully harness the power of RNA technology for human therapeutics, our platform continues to
revolutionize drug discovery and transform the lives of patients with unmet needs. Our medicines span multiple therapeutic
areas, routes of administration and diverse patient populations. Ionis innovation is driving meaningful progress for many of the
most challenging health issues.
We are building upon our innovative research and drug development excellence to provide greater value to patients. Based on
the breadth and remarkable progress of our pipeline, Ionis is projecting to have a vast number of new transformational
products on the market in the coming years and growing our commercial capabilities. We are well positioned financially to
deliver on our strategic goals.
Ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. Our
success is a direct result of our outstanding employees. We are interested in bringing together a diverse workforce, comprised
of individuals from different backgrounds and with unique skill sets, into our creative and productive environment. Join us and
experience our unique culture while you develop and expand your career.
Ionis Pharmaceuticals, Inc., one of the 2020 Best Places to Work in San Diego, is in the North San Diego County city of
Carlsbad. For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing
standards of care with our novel antisense technology. Ionis currently has three marketed medicines – Spinraza, the standard
of care for all forms of spinal muscular atrophy; Tegsedi, the first approved RNA-targeted therapy for polyneuropathy caused
by hereditary ATTR (transthyretin) amyloidosis; and Waylivra, the only approved treatment for familial chylomicronemia
syndrome (FCS). Ionis has a premier late-stage pipeline highlighted by our industry-leading neurological and cardiometabolic
franchises. Scientific innovation began and continues at Ionis with the understanding that sick people depend on the success
of the company. This belief drives Ionis’ vision of becoming one of the most successful biotechnology companies.
As the first company to fully harness the power of RNA technology for human therapeutics, Ionis’ platform continues to
revolutionize drug discovery and transform lives for patients with unmet needs. Ionis’ medicines span multiple therapeutic
areas, routes of administration and diverse patient populations, and Ionis innovation is driving meaningful progress for many
of the most challenging health issues.
Ionis is building upon our innovative research and drug development excellence to provide greater value to patients. Based on
the breadth and remarkable progress of our pipeline, Ionis is projecting to have a vast number of new transformational
products on the market in the coming years. Ionis is well positioned financially to deliver on our strategic goals.
Ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. Our
success is a direct result of our outstanding employees. We are interested in bringing together individuals with different skill
sets into this creative environment to be part of a productive team. Join us and experience our unique culture while you
develop and expand your career.